There were five finalists presenting at the Alexa Diabetes Challenge enlisting Amazon’s voice-activated, machine learning-enabled robot in New York City this week at Merck’s event. But one application that resonated strongly with attendees involves the potential to improve the mood of diabetes patients, many of whom struggle with depression that comes with coping with being diagnosed with a chronic condition associated with potentially life-threatening complications.
